Quarterly Results
TLX Earnings Forecast
Looking ahead, TLX remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of undefined and an EPS of undefined.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 4.15%, while EPS estimates have been Revise Downward by -46.8%. For the upcoming Q3 2025, revenue estimates have been adjusted No Change by 0% . These revisions correlate with a -24.38% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in TLX long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Earnings Forecast
Revenue
EPS
Currency:

No data
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how TLX performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TLX sees a +9.12% change in stock price 10 days leading up to the earnings, and a -17.23% change 10 days following the report. On the earnings day itself, the stock moves by -2.92%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed 10.21% on the day following the earnings release and then changed by -17.23% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of TLX's latest earnings report for ?
TLX reported its earnings on 2025-08-20, showcasing a revenue of 204.00M against an estimate of 204.28M, resulting in a -0.14% surprise. The EPS was 0.18, surpassing the expected 0.12 by 53.42% . The stock experienced a 10.21% price change on the earnings day and a 14.31% change over the next five days, reflecting market reactions to the results.
How did TLX's stock price react after the earnings release?
Following TLX's earnings announcement on 2025-08-20, the stock price moved by 10.21% on the day of the release. Over the subsequent five days, it saw a 14.31% change. Historically, TLX's stock price tends to shift by an average of +9.12% in the 10 days leading up to earnings and -17.23% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for TLX for undefined?
For , analysts estimate TLX’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 4.15% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.
How does TLX's stock price correlate with earnings forecast revisions?
The correlation between TLX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 4.15%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from TLX's next earnings report?
Based on historical trends, TLX's stock price typically moves by +9.12% in the 10 days before its earnings and -17.23% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.
What is the sentiment in Telix Pharmaceuticals Ltd (TLX) Q2 2025 Earnings Call Summary?
The earnings call reveals strong financial performance with a 63% revenue increase, stable gross margins, and a healthy cash position. The company's expansion and new product developments, such as the BiPASS study and Zircaix approvals, signal future growth. Despite risks like SEC inquiries and pricing pressures, the strategic integration of RLS and global manufacturing investments support a positive outlook. While the Q&A section lacks clarity, overall, the positive financial and strategic developments suggest a likely stock price increase in the coming weeks.

